EWS-FLI1 employs an E2F switch to drive target gene expression

Nucleic Acids Research

Volumn 43, Issue 5, 2015, Pages 2780-2789

  Schwentner, Raphaela ^a   Papamarkou, Theodore ^b   Kauer, Maximilian O ^a   Stathopoulos, Vassilios ^b   Yang, Fan ^c   Bilke, Sven ^c   Meltzer, Paul S ^c   Girolami, Mark ^b   Kovar, Heinrich ^a,d  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FRIEND LEUKEMIA VIRUS INTEGRATION SITE 1 PROTEIN; HYBRID PROTEIN; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; E2F3 PROTEIN, HUMAN; E2F4 PROTEIN, HUMAN; EWS-FLI FUSION PROTEIN; ONCOPROTEIN; PROTEIN BINDING; TRANSCRIPTION FACTOR E2F3; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR FLI 1;

ARTICLE; BAYES THEOREM; CELL ACTIVATION; CELL CYCLE; CONTROLLED STUDY; EWING SARCOMA; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; KINETICS; MATHEMATICAL MODEL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; STATISTICAL MODEL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ALGORITHM; BIOLOGICAL MODEL; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE;

ALGORITHMS; BAYES THEOREM; CELL CYCLE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; E2F3 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; MODELS, GENETIC; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEIN C-FLI-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA-BINDING PROTEIN EWS; SARCOMA, EWING;

EID: 84937435859     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv123     Document Type: Article

References (37)

1. Kovar, H. (2010) Downstream EWS/FLI1 - upstream Ewing's sarcoma. Genome Med., 2, 8.
2. Bernstein, M., Kovar, H., Paulussen, M., Randall, R. L., Schuck, A., Teot, L. A. and Juergens, H. (2006) Ewing's sarcoma family of tumors: current management. Oncologist, 11, 503-519.
3. Kauer, M., Ban, J., Kofler, R., Walker, B., Davis, S., Meltzer, P. and Kovar, H. (2009) A molecular function map of Ewing's sarcoma. PLoS One, 4, e5415.
4. Crosby, M. E. and Almasan, A. (2004) Opposing roles of E2Fs in cell proliferation and death. Cancer Biol. Ther., 3, 1208-1211.
5. Hallstrom, T. C. and Nevins, J. R. (2009) Balancing the decision of cell proliferation and cell fate. Cell Cycle, 8, 532-535.
6. Polager, S. and Ginsberg, D. (2009) p53 and E2f: partners in life and death. Nat. Rev. Cancer, 9, 738-748.
7. Chen, H. Z., Tsai, S. Y. and Leone, G. (2009) Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat. Rev. Cancer, 9, 785-797.
8. Swiss, V. A. and Casaccia, P. (2010) Cell-context specific role of the E2F/Rb pathway in development and disease. Glia, 58, 377-390.
9. Danielian, P. S., Friesenhahn, L. B., Faust, A. M., West, J. C., Caron, A. M., Bronson, R. T. and Lees, J. A. (2008) E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity. Oncogene, 27, 6561-6570.
10. Chong, J. L., Wenzel, P. L., Saenz-Robles, M. T., Nair, V., Ferrey, A., Hagan, J. P., Gomez, Y. M., Sharma, N., Chen, H. Z., Ouseph, M. et al. (2009) E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature, 462, 930-934.
11. Takahashi, Y., Rayman, J. B. and Dynlacht, B. D. (2000) Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev., 14, 804-816.
12. Cam, H., Balciunaite, E., Blais, A., Spektor, A., Scarpulla, R. C., Young, R., Kluger, Y. and Dynlacht, B. D. (2004) A common set of gene regulatory networks links metabolism and growth inhibition. Mol. Cell, 16, 399-411.
13. Van Den Heuvel, S. and Dyson, N. J. (2008) Conserved functions of the pRB and E2F families. Nat. Rev. Mol. Cell Biol., 9, 713-724.
14. Bilke, S., Schwentner, R., Yang, F., Kauer, M., Jug, G., Walker, R. L., Davis, S., Zhu, Y. J., Pineda, M., Meltzer, P. S. et al. (2013) Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer. Genome Res., 23, 1797-1809.
15. Carrillo, J., Garcia-Aragoncillo, E., Azorin, D., Agra, N., Sastre, A., Gonzalez-Mediero, I., Garcia-Miguel, P., Pestana, A., Gallego, S., Segura, D. et al. (2007) Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth. Clin. Cancer Res., 13, 2429-2440.
16. Li, H. and Durbin, R. (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 25, 1754-1760.
17. Schmittgen, T. D. and Livak, K. J. (2008) Analyzing real-time PCR data by the comparative C (T) method. Nat. Protoc., 3, 1101-1108.
18. Friel, N. and Pettitt, A. N. (2008) Marginal likelihood estimation via power posteriors. J. R. Stat. Soc. B, 70, 589-607.
19. Girolami, M. and Calderhead, B. (2011) Riemann manifold Langevin and Hamiltonian Monte Carlo methods. J. R. Stat. Soc. B, 73, 123-214.
20. Locke, J. C., Southern, M. M., Kozma-Bognar, L., Hibberd, V., Brown, P. E., Turner, M. S. and Millar, A. J. (2005) Extension of a genetic network model by iterative experimentation and mathematical analysis. Mol. Syst. Biol., 1, 2005-0013.
21. Calderhead, B. and Girolami, M. (2011) Statistical analysis of nonlinear dynamical systems using differential geometric sampling methods. Interface Focus, 1, 821-835.
22. Hu, H. M., Zielinska-Kwiatkowska, A., Munro, K., Wilcox, J., Wu, D. Y., Yang, L. and Chansky, H. A. (2008) EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells. J. Orthop. Res., 26, 886-893.
23. Hirata, M., Kugimiya, F., Fukai, A., Ohba, S., Kawamura, N., Ogasawara, T., Kawasaki, Y., Saito, T., Yano, F., Ikeda, T. et al. (2009) C/EBPbeta Promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57. PLoS One, 4, e4543.
24. Jackman, J. and O'Connor, P. M. (2001) Methods for synchronizing cells at specific stages of the cell cycle. In: Bonifacino, J. S., Dasso, M., Harford, J. B., Lippincott-Schwartz, J. and Yamada, K. M. (eds). Curr. Protoc Cell Biol. John Wiley & Sons, Inc, Hoboken, NJ, Chapter 8, Unit 8-3.
25. Henley, S. A. and Dick, F. A. (2012) The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle. Cell Div., 7, 10.
26. De Gregori, J. (2002) The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim. Biophys. Acta, 1602, 131-150.
27. Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
28. Mangan, S. and Alon, U. (2003) Structure and function of the feed-forward loop network motif. Proc. Natl. Acad. Sci. U. S. A., 100, 11980-11985.
29. Tirode, F., Laud-Duval, K., Prieur, A., Delorme, B., Charbord, P. and Delattre, O. (2007) Mesenchymal stem cell features of Ewing tumors. Cancer Cell, 11, 421-429.
30. Lipinski, M., Braham, K., Philip, I., Wiels, J., Philip, T., Goridis, C., Lenoir, G. M. and Tursz, T. (1987) Neuroectoderm-associated antigens on Ewing's sarcoma cell lines. Cancer Res., 47, 183-187.
31. Von Levetzow, C., Jiang, X., Gwye, Y., Von Levetzow, G., Hung, L., Cooper, A., Hsu, J. H. and Lawlor, E. R. (2011) Modeling initiation of Ewing sarcoma in human neural crest cells. PloS One, 6, e19305.
32. Tanaka, M., Yamazaki, Y., Kanno, Y., Igarashi, K., Aisaki, K., Kanno, J. and Nakamura, T. (2014) Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors. J. Clin. Invest., 124, 3061-3074.
33. Freedman, J. A., Chang, J. T., Jakoi, L. and Nevins, J. R. (2009) A combinatorial mechanism for determining the specificity of E2F activation and repression. Oncogene, 28, 2873-2881.
34. Li, Y., Zhang, D. Y., Ren, Q., Ye, F., Zhao, X., Daniels, G., Wu, X., Dynlacht, B. and Lee, P. (2012) Regulation of a novel androgen receptor target gene, cyclin B1, through androgen-dependent E2F family member switching. Mol. Cell. Biol., 32, 2454-2466.
35. Li, Y., Li, X., Fan, G., Fukushi, J., Matsumoto, Y., Iwamoto, Y. and Zhu, Y. (2012) Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing Family Tumors. Cancer Lett., 320, 14-22.
36. Rayman, J. B., Takahashi, Y., Indjeian, V. B., Dannenberg, J. H., Catchpole, S., Watson, R. J., Te Riele, H. and Dynlacht, B. D. (2002) E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev., 16, 933-947.
37. Erkizan, H. V., Kong, Y., Merchant, M., Schlottmann, S., Barber-Rotenberg, J. S., Yuan, L., Abaan, O. D., Chou, T. H., Dakshanamurthy, S., Brown, M. L. et al. (2009) A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma. Nat. Med., 15, 750-756.